XRTX

XORTX Therapeutics Inc.

Healthcare · Biotechnology

$87.83 sample

-0.76 (-0.86%) 1D

Market cap

$320.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-25

Alerts

8

Price$87.83 +3.50% 3M daily closessample

89.4284.11

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: EVP, Operations
Oct 02INSInsider sell: 10% owner
Sep 25SECDEF 14A filed
Sep 21INSInsider buy: Chief Executive Officer
Sep 16SEC10-Q filed
Sep 09INSInsider sell: Chief Financial Officer
Sep 04INSInsider buy: EVP, Operations
Aug 26INSInsider sell: Chief Financial Officer

Sign up to see the real XRTX record →

Company facts

SEC EDGAR registration

Name: XORTX Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -26sample, -100 to +100
Reporting currency: USD

Who is positioning in XRTX

sample

Insiders: 15 insider transactions over 90 days, net selling, $857.9M
Congress: No member trades over 90 days
Institutions · 13F: 18 funds hold $6.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$19.8B +12.9% y/y

Q4 2024Q3 2026

Inventory$11.4B +8.0% y/y

Q4 2024Q3 2026

Accounts receivable$9.1B +16.3% y/y

Q4 2024Q3 2026

Total debt$22.9B +3.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $279.7B +1.5% 3M
Sample peer B: $66.9B -12.2% 3M
Sample peer C: $281.2B -7.9% 3M
Sample peer D: $190.1B +14.1% 3M
Sample peer E: $49.9B +15.0% 3M